Sudarshan Pharma Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003813, "name": "Sudarshan Pharma", "stock_name": "Sudarshan Pharma", "full_name": "Sudarshan Pharma Industries Ltd", "name_url": "stocks-analysis/sudarshan-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "38.10", "chg": -0.51, "chgp": "-1.32%", "dir": -1, "prev_price": "38.61", "mcapval": "961.00 Cr", "mcap": "Micro Cap", "scripcode": 543828, "symbol": "", "ind_name": "Specialty Chemicals", "ind_code": 4, "sector_id": 74, "indexname": "India SENSEX", "isin": "INE00TV01023", "curr_date": "Sep 02, 12:53 PM", "curr_time": "13:13 PM", "last_traded_at": "Sep 02, 12:53 PM IST", "bse_nse_vol": 3224000, "exc_status": "Active", "traded_date": "Sep 02, 2026", "traded_date_str": "2026 09 02", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sudarshan Pharma Industries Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-4179572", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SudarshanPharma_mojoScore_4179572.png", "date": "2026-09-02 10:10:26", "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Sudarshan Pharma Industries Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-4164918", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SudarshanPharma_mojoScore_4164918.png", "date": "2026-08-22 10:10:15", "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Sudarshan Pharma Gains 6.79%: Mixed Technical and Financial Signals Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-gains-679-mixed-technical-and-financial-signals-shape-the-week-4155287", "imagepath": "", "date": "2026-08-15 11:00:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> Stock opens at ₹32.30 after a 5.00% drop</p>\n <p><strong>11 Aug:</strong> Technical momentum shift amid market volatility</p>\n <p><strong>13 Aug:</strong> Mixed quarterly financial trend reported</p>\n <p><strong>14 Aug:</strong> Mild bullish technical signals emerge</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.34.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.36.31</div><div class=\"stat-change positive..." }, { "title": "Sudarshan Pharma Industries Ltd Reports Flat Financial Trend Amid Mixed Quarterly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-reports-flat-financial-trend-amid-mixed-quarterly-performance-4151882", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SudarshanPharma_fintrenddot_4151882.png", "date": "2026-08-13 11:00:56", "description": "Sudarshan Pharma Industries Ltd, a micro-cap player in the specialty chemicals sector, has reported a flat financial performance for the quarter ended June 2026, marking a notable shift from its previously positive growth trajectory. Despite robust sales and profit growth over the last six months, rising interest expenses and margin pressures have weighed on the company’s overall financial health, prompting a downgrade in its Mojo Grade from Buy to Hold." }, { "title": "Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4151120", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SudarshanPharma_technicaldot_4151120.png", "date": "2026-08-13 08:03:34", "description": "Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent price action and moving averages suggest a cautiously optimistic outlook for investors." }, { "title": "Are Sudarshan Pharma Industries Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-sudarshan-pharma-industries-ltd-latest-results-good-or-bad-4150611", "imagepath": "", "date": "2026-08-12 19:38:48", "description": "Sudarshan Pharma Industries Ltd's latest financial results reflect a complex operational landscape characterized by strong revenue growth alongside significant challenges related to profitability and financial leverage. For the quarter ended March 2026, the company reported net sales of ₹220.92 crores, marking a year-on-year growth of 36.72% and a sequential increase of 31.49%. This performance indicates robust demand for its specialty chemical products, achieving the highest quarterly revenue in its recent history.\n\nHowever, the company's operational efficiency is constrained by rising interest costs, which reached ₹7.53 crores in this quarter, the highest recorded in recent periods. This increase in interest expenses, coupled with a debt-to-EBITDA ratio of 5.22 and a net debt-to-equity ratio of 1.54, underscores the financial leverage that limits Sudarshan Pharma's operational flexibility. The operating m..." }, { "title": "Sudarshan Pharma Industries Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-by-marketsmojo-4147403", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SudarshanPharma_mojoScore_4147403.png", "date": "2026-08-11 10:10:03", "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Sudarshan Pharma Industries Ltd Faces Technical Momentum Shift Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-faces-technical-momentum-shift-amid-market-volatility-4146561", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SudarshanPharma_technicaldot_4146561.png", "date": "2026-08-11 08:08:46", "description": "Sudarshan Pharma Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent 5.00% decline in the stock price to ₹32.30, the company’s longer-term returns remain robust, though technical indicators present a mixed picture that warrants close attention from investors." }, { "title": "Sudarshan Pharma Falls 9.40%: Mixed Technicals and Debt Concerns Shape Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-falls-940-mixed-technicals-and-debt-concerns-shape-weekly-decline-4131350", "imagepath": "", "date": "2026-08-01 11:02:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock opens at ₹41.43, declines 0.93%</p>\n <p><strong>28 Jul:</strong> Sharp drop of 4.13% to ₹39.72 on low volume</p>\n <p><strong>29 Jul:</strong> Brief recovery with 1.76% gain to ₹40.42</p>\n <p><strong>30 Jul:</strong> Downgrade to Hold announced; stock falls 4.45%</p>\n <p><strong>31 Jul:</strong> Continued decline to ₹37.89, closing the week down 9.40%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.41.82</div></div>\n <div class=\"stat-item\"..." } ], "total": 177, "sid": "1003813", "stock_news_url": "https://www.marketsmojo.com/news/sudarshan-pharma-industries-1003813" }, "announcements": [ { "caption": "Annual General Meeting Of The Company On Tuesday 22/September/2026", "datetime": "29-Aug-2026", "details": "Pursuant to Regulation 34 of SEBI Listing Regulations please find enclosed the Notice of 18th Annual General Meeting to be held on Tuesday 22/September/2026.", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "29-Aug-2026", "details": "Pursuant to Reg 34 of SEBI Listing Regulations please find enclosed the Annual Report of the Company for the FY 2025-26.", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "29-Aug-2026", "details": "Pursuant to Reg 34 of SEBI Listing Regulations please find enclosed the Annual Report of the Company for the FY 2025-26.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23", "dt": "2023-08-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24", "dt": "2024-11-22", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

10 Aug: Stock opens at ₹32.30 after a 5.00% drop

11 Aug: Technical momentum shift amid market volatility

13 Aug: Mixed quarterly financial trend reported

14 Aug: Mild bullish technical signals emerge

Read full news article

Sudarshan Pharma Industries Ltd Reports Flat Financial Trend Amid Mixed Quarterly Performance

2026-08-13 11:00:56

Sudarshan Pharma Industries Ltd, a micro-cap player in the specialty chemicals sector, has reported a flat financial performance for the quarter ended June 2026, marking a notable shift from its previously positive growth trajectory. Despite robust sales and profit growth over the last six months, rising interest expenses and margin pressures have weighed on the company’s overall financial health, prompting a downgrade in its Mojo Grade from Buy to Hold.

Read full news article

Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-13 08:03:34

Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent price action and moving averages suggest a cautiously optimistic outlook for investors.

Read full news article

Are Sudarshan Pharma Industries Ltd latest results good or bad?

2026-08-12 19:38:48

Sudarshan Pharma Industries Ltd's latest financial results reflect a complex operational landscape characterized by strong revenue growth alongside significant challenges related to profitability and financial leverage. For the quarter ended March 2026, the company reported net sales of ₹220.92 crores, marking a year-on-year growth of 36.72% and a sequential increase of 31.49%. This performance indicates robust demand for its specialty chemical products, achieving the highest quarterly revenue in its recent history. However, the company's operational efficiency is constrained by rising interest costs, which reached ₹7.53 crores in this quarter, the highest recorded in recent periods. This increase in interest expenses, coupled with a debt-to-EBITDA ratio of 5.22 and a net debt-to-equity ratio of 1.54, underscores the financial leverage that limits Sudarshan Pharma's operational flexibility. The operating m...

Read full news article

Sudarshan Pharma Industries Ltd is Rated Hold by MarketsMOJO

2026-08-11 10:10:03

Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Sudarshan Pharma Industries Ltd Faces Technical Momentum Shift Amid Market Volatility

2026-08-11 08:08:46

Sudarshan Pharma Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent 5.00% decline in the stock price to ₹32.30, the company’s longer-term returns remain robust, though technical indicators present a mixed picture that warrants close attention from investors.